A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir in Patients With Herpes Zoster.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Valnivudine (Primary) ; Valaciclovir
- Indications Herpes zoster; Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 13 Dec 2010 Top-line results were reported in an Inhibitex media release.
- 08 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Oct 2010 Enrollment completed, according to an Inhibitex media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History